Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00733798
What this trial is testing

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Who this might be right for
MelanomaMalignant MelanomaMetastatic Melanoma
TransMolecular 58
Large-scale testing (Phase 3)Study completedNCT00518895
What this trial is testing

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Who this might be right for
Melanoma
Genta Incorporated 300
Early research (Phase 1)Study completedNCT01011530
What this trial is testing

Dose Escalation Study of MLN4924 in Adults With Melanoma

Who this might be right for
Metastatic Melanoma
Millennium Pharmaceuticals, Inc. 37
Early research (Phase 1)Study completedNCT00658892
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00948467
What this trial is testing

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Non-hematologic MalignanciesAdvanced Metastatic Melanoma
Millennium Pharmaceuticals, Inc. 51
Testing effectiveness (Phase 2)Study completedNCT00086489
What this trial is testing

CP-675,206 In Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
AstraZeneca 118
Testing effectiveness (Phase 2)Study completedNCT00597038
What this trial is testing

A Phase I/II Study of Dasatinib and Dacarbazine

Who this might be right for
Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute 50
Testing effectiveness (Phase 2)Study completedNCT01253096
What this trial is testing

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 25
Testing effectiveness (Phase 2)Study completedNCT00002952
What this trial is testing

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Chicago 20
Not applicableStudy completedNCT02862743
What this trial is testing

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling

Who this might be right for
Metastatic Melanoma
CHU de Reims 50
Early research (Phase 1)Study completedNCT04551352
What this trial is testing

RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Who this might be right for
Cutaneous MelanomaUveal MelanomaMucosal Melanoma
Hoffmann-La Roche 20
Early research (Phase 1)Study completedNCT01103635
What this trial is testing

Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Abramson Cancer Center at Penn Medicine 25
Early research (Phase 1)UnknownNCT00022568
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00734188
What this trial is testing

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Pain Therapeutics 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07803562
What this trial is testing

Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp

Who this might be right for
Uveal Melanoma, Metastatic
University of California, San Diego 34
Testing effectiveness (Phase 2)Ended earlyNCT01369888
What this trial is testing

Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT01495572
What this trial is testing

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT05104801
What this trial is testing

Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 37
Testing effectiveness (Phase 2)Ended earlyNCT03728465
What this trial is testing

Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma

Who this might be right for
Metastatic MelanomaBrain Metastases
University Hospital Tuebingen 6
Testing effectiveness (Phase 2)Ended earlyNCT01604889
What this trial is testing

A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Incyte Corporation 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation